Phillip E. Morgan

1.1k total citations
29 papers, 811 citations indexed

About

Phillip E. Morgan is a scholar working on Spectroscopy, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Phillip E. Morgan has authored 29 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Spectroscopy, 6 papers in Molecular Biology and 6 papers in Analytical Chemistry. Recurrent topics in Phillip E. Morgan's work include Analytical Chemistry and Chromatography (7 papers), Pesticide Residue Analysis and Safety (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Phillip E. Morgan is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Pesticide Residue Analysis and Safety (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Phillip E. Morgan collaborates with scholars based in United Kingdom, Australia and United States. Phillip E. Morgan's co-authors include Robert J. Flanagan, Lewis Couchman, Edgar P. Spencer, Stephen W. McKechnie, Simon A. Handley, Danielle S. Fisher, Robin Whelpton, Nigel W. Brown, J. Michael Tredger and Antonio Pagliuca and has published in prestigious journals such as Nature, Hepatology and Neuropsychopharmacology.

In The Last Decade

Phillip E. Morgan

29 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip E. Morgan United Kingdom 16 184 166 138 109 105 29 811
Robert F. Mayol United States 18 116 0.6× 323 1.9× 101 0.7× 80 0.7× 131 1.2× 32 1.0k
Ross Dixon United States 21 51 0.3× 390 2.3× 79 0.6× 53 0.5× 174 1.7× 50 1.3k
Lucia Pötsch Germany 23 29 0.2× 153 0.9× 142 1.0× 68 0.6× 140 1.3× 50 1.3k
Cristiana Gambelunghe Italy 17 36 0.2× 134 0.8× 60 0.4× 38 0.3× 71 0.7× 50 1.1k
Eva Cuypers Belgium 24 20 0.1× 550 3.3× 321 2.3× 164 1.5× 126 1.2× 67 1.4k
Ryoji Matoba Japan 18 19 0.1× 272 1.6× 41 0.3× 38 0.3× 175 1.7× 67 887
David M. Andrenyak United States 20 28 0.2× 431 2.6× 183 1.3× 50 0.5× 363 3.5× 37 1.3k
Alexander Mueller Australia 20 84 0.5× 443 2.7× 28 0.2× 10 0.1× 192 1.8× 47 1.1k
Elena Lendoiro Spain 21 15 0.1× 166 1.0× 159 1.2× 90 0.8× 132 1.3× 49 1.0k
Michael Franklin United Kingdom 17 127 0.7× 131 0.8× 48 0.3× 45 0.4× 82 0.8× 44 861

Countries citing papers authored by Phillip E. Morgan

Since Specialization
Citations

This map shows the geographic impact of Phillip E. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip E. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip E. Morgan more than expected).

Fields of papers citing papers by Phillip E. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip E. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip E. Morgan. The network helps show where Phillip E. Morgan may publish in the future.

Co-authorship network of co-authors of Phillip E. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip E. Morgan. A scholar is included among the top collaborators of Phillip E. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip E. Morgan. Phillip E. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trovato, Francesca M., Salma Mujib, Ellen Jerome, et al.. (2022). Immunometabolic analysis shows a distinct cyto-metabotype in Covid-19 compared to sepsis from other causes. Heliyon. 8(6). e09733–e09733. 3 indexed citations
2.
Underhill, James A., Abdel Douiri, Alberto Quaglia, et al.. (2021). The Influence of Donor and Recipient Complement C3 Polymorphisms on Liver Transplant Outcome. International Journal of Hepatology. 2021. 1–14. 1 indexed citations
3.
Brown, Nigel W., Phillip E. Morgan, Kosh Agarwal, & J. Michael Tredger. (2015). Concentration Monitoring of Plasma Ribavirin. Therapeutic Drug Monitoring. 38(1). 50–58. 3 indexed citations
4.
Morgan, Phillip E., Nigel W. Brown, & J. Michael Tredger. (2013). A Direct Method for the Measurement of Everolimus and Sirolimus in Whole Blood by LC–MS/MS Using an Isotopic Everolimus Internal Standard. Therapeutic Drug Monitoring. 36(3). 358–365. 24 indexed citations
5.
Couchman, Lewis, et al.. (2012). An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 404(2). 513–523. 25 indexed citations
6.
Ceesay, M. Mansour, et al.. (2011). Measurement of Posaconazole, Itraconazole, and Hydroxyitraconazole in Plasma/Serum by High-Performance Liquid Chromatography With Fluorescence Detection. Therapeutic Drug Monitoring. 33(6). 735–741. 15 indexed citations
7.
Couchman, Lewis & Phillip E. Morgan. (2010). LC‐MS in analytical toxicology: some practical considerations. Biomedical Chromatography. 25(1-2). 100–123. 53 indexed citations
8.
Couchman, Lewis, Phillip E. Morgan, Edgar P. Spencer, A. E. Johnston, & Robert J. Flanagan. (2010). Plasma Clozapine and Norclozapine in Patients Prescribed Different Brands of Clozapine (Clozaril, Denzapine, and Zaponex). Therapeutic Drug Monitoring. 32(5). 624–627. 14 indexed citations
9.
Morgan, Phillip E., et al.. (2010). A rapid and simple assay for lamotrigine in serum/plasma by HPLC, and comparison with an immunoassay. Biomedical Chromatography. 25(7). 775–778. 15 indexed citations
10.
Couchman, Lewis, Phillip E. Morgan, Edgar P. Spencer, & Robert J. Flanagan. (2010). Plasma Clozapine, Norclozapine, and the Clozapine:Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993–2007. Therapeutic Drug Monitoring. 32(4). 438–447. 128 indexed citations
11.
Couchman, Lewis, Phillip E. Morgan, & Robert J. Flanagan. (2010). Basic drug analysis by strong cation‐exchange liquid chromatography–tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum/plasma. Biomedical Chromatography. 25(8). 867–872. 14 indexed citations
12.
Morgan, Phillip E., et al.. (2009). HPLC of basic drugs using non‐aqueous ionic eluents: evaluation of a 3 μm strong cation‐exchange material. Biomedical Chromatography. 24(3). 318–323. 10 indexed citations
13.
Yau, Joyce L.W., June Noble, Sarah Thomas, et al.. (2007). The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice. Neuropsychopharmacology. 32(12). 2520–2529. 42 indexed citations
14.
Wood, David M., et al.. (2007). Status epilepticus following intentional overdose of fluvoxamine: A case report with serum fluvoxamine concentration. Clinical Toxicology. 45(7). 791–793. 19 indexed citations
15.
Flanagan, Robert J., Phillip E. Morgan, Edgar P. Spencer, & Robin Whelpton. (2006). Micro‐extraction techniques in analytical toxicology: short review. Biomedical Chromatography. 20(6-7). 530–538. 37 indexed citations
16.
Morgan, Phillip E., Melissa Hanna‐Brown, & Robert J. Flanagan. (2005). Characterization of a microparticulate strong anion‐exchanger in the HPLC of acidic drugs. Biomedical Chromatography. 20(8). 765–773. 4 indexed citations
17.
Morgan, Phillip E., et al.. (2004). Analysis of clozapine and norclozapine in plasma using automated online sample preparation and LC-MS/MS. 2 indexed citations
18.
Morgan, Phillip E., et al.. (2003). Measurement of total mirtazapine and normirtazapine in plasma/serum by liquid chromatography with fluorescence detection. Journal of Chromatography B. 798(2). 211–215. 25 indexed citations
19.
McKechnie, Stephen W. & Phillip E. Morgan. (1982). Alcohol Dehydrogenase Polymorphism of Drosophila melanogaster: Aspects of Alcohol and Temperature Variation in the Larval Environment. Australian Journal of Biological Sciences. 35(1). 85–94. 73 indexed citations
20.
Morgan, Phillip E.. (1976). Frequency-dependent selection at two enzyme loci in Drosophila melanogaster. Nature. 263(5580). 765–766. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert F. Mayol Breakdown of academic impact, for papers by Ross Dixon Breakdown of academic impact, for papers by Lucia Pötsch Breakdown of academic impact, for papers by Cristiana Gambelunghe Breakdown of academic impact, for papers by Eva Cuypers Breakdown of academic impact, for papers by Ryoji Matoba Breakdown of academic impact, for papers by David M. Andrenyak Breakdown of academic impact, for papers by Alexander Mueller Breakdown of academic impact, for papers by Elena Lendoiro Breakdown of academic impact, for papers by Michael Franklin
Rankless by CCL
2026